155 related articles for article (PubMed ID: 1437337)
1. Lung mechanics and gas exchange in ventilated preterm infants during treatment of hyaline membrane disease with multiple doses of artificial surfactant (Exosurf).
Pfenninger J; Aebi C; Bachmann D; Wagner BP
Pediatr Pulmonol; 1992 Sep; 14(1):10-5. PubMed ID: 1437337
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
[TBL] [Abstract][Full Text] [Related]
3. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
[TBL] [Abstract][Full Text] [Related]
4. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
[TBL] [Abstract][Full Text] [Related]
6. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
7. Respiratory mechanics before and after late artificial surfactant rescue.
Todd DA; Choukroun ML; Fayon M; Kays C; Guénard H; Galpérine I; Demarquez JL
J Paediatr Child Health; 1995 Dec; 31(6):532-6. PubMed ID: 8924306
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
Bhutani VK; Abbasi S; Long WA; Gerdes JS
J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
[TBL] [Abstract][Full Text] [Related]
9. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
10. Delayed compliance increase in infants with respiratory distress syndrome following synthetic surfactant.
Armsby DH; Bellon G; Carlisle K; Rector D; Baldwin R; Long W; Stevenson DK; Ariagno RL
Pediatr Pulmonol; 1992 Dec; 14(4):206-13. PubMed ID: 1484754
[TBL] [Abstract][Full Text] [Related]
11. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Malathi I; Ng KC
Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
[TBL] [Abstract][Full Text] [Related]
12. Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry.
Huang YC; Sane AC; Simonson SG; Fawcett TA; Moon RE; Fracica PJ; Menache MG; Piantadosi CA; Young SL
J Appl Physiol (1985); 1995 May; 78(5):1816-22. PubMed ID: 7649917
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
Goldman SL; Bosque E; McCann E; Lewis K
J Pediatr; 1992 Feb; 120(2 Pt 2):S25-8. PubMed ID: 1735847
[TBL] [Abstract][Full Text] [Related]
14. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome.
Hudak ML; Farrell EE; Rosenberg AA; Jung AL; Auten RL; Durand DJ; Horgan MJ; Buckwald S; Belcastro MR; Donohue PK; Carrion V; Maniscalco WW; Balsan MJ; Torres BA; Miller RR; Jansen RD; Graeber JE; Laskay KM; Matteson EJ; Egan EA; Brody AS; Martin DJ; Riddlesberger MM; Montgomery P
J Pediatr; 1996 Mar; 128(3):396-406. PubMed ID: 8774514
[TBL] [Abstract][Full Text] [Related]
15. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A
Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244
[TBL] [Abstract][Full Text] [Related]
16. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
Sandberg KL; Lindstrom DP; Sjöqvist BA; Parker RA; Cotton RB
Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
[TBL] [Abstract][Full Text] [Related]
17. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
[TBL] [Abstract][Full Text] [Related]
18. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
20. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome.
Billman D; Nicks J; Schumacher R
Pediatr Pulmonol; 1994 Nov; 18(5):279-83. PubMed ID: 7898965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]